Alacris Theranostics enters agreement with GSK
To use ModCell System for early stage cancer research
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharmexcil spells out clarifications from MoH&FW
Pharma exports, imports, med devices not covered by October notification
Sun Pharma to acquire DUSA Pharmaceuticals
A 100 per cent subsidiary of Sun Pharmaceutical Industries will commence a tender offer for all of the outstanding common stock of…
Indegene to acquire marketing services business assets of Canada-based Aptilon
To help clients accelerate their physician engagement strategies
Cipla announces major price reduction on select cancer drugs
Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients
Sun Pharma to acquire DUSA Pharmaceuticals
DUSA’s Levulan combination therapy is for treatment of non-hyperkeratotic actinic keratoses
Quintiles study confirms validity of data from patients recruited over Internet
Lays foundation for direct-to-patient studies using patient reported outcomes + medical record methods
Novartis phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients…
RLX030 is the first in a new class of medicines and the only agent to show a reduction in mortality in AHF